Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

In other stroke news, Dr. Mark Williams (Board of Director @ Algernon Pharma|ceuticals Inc) former employer Diamedica Therapeutics, Phase 2/3 stroke clinical trial gets torpedoed by the FDA. Dr. Williams is a coinventor of DM199.

https://www.businesswire.com/news/home/20220706005843/en/DiaMedica-Therapeutics-Announces-Clinical-Hold-of-its-Phase-23-ReMEDy2-Clinical-Trial-for-DM199

OAN: The announcement today of the start of Algernon's DMT stroke study would appear to be a distraction from the still awaited IPF/Chronic Cough Topline data readout. My best guess is the results will be underwhelming. Thus, you're thrown a piece of red meat to push your mind further down the road. If you're told a study will start in one particular quarter, add a couple more quarters to the story and hold onto your @ss.

On with the show this is it.

M$